HORSHAM, PA, August 16, 2018 – Leading life sciences and healthcare executive search firm, Klein Hersh is pleased to announce the placements of Alan A. Musso as Chief Financial Officer (CFO) of Peloton Therapeutics and Peter P. Pfreundschuh as CFO of UroGen Pharma.
Mr. Musso brings significant financial expertise and operational leadership to Peloton. As the company’s first CFO, Mr. Musso will be responsible for corporate financing activities, investor relations, accounting, human resources, information systems, and operations. He will report to John A. Josey, Ph.D., Peloton’s Chief Executive Officer.
Mr. Pfreundschuh brings more than two decades of executive leadership experience in life sciences to UroGen. Stephen Mullennix, who has served as UroGen’s interim CFO since June 2018, will continue in his role as the Company’s Chief Operating Officer.
Marc Miller and Jared Kaleck led the Peloton and UroGen executive searches.
Klein Hersh is a premier executive search firm focusing solely on delivering strategic leadership placement solutions to the life sciences and healthcare industries. The firm’s subject matter experts and practice leaders deliver superior quality service throughout every step of the comprehensive search process. Exemplified by the more than 300 executive hires annually – from healthcare-focused venture capital firms to Fortune 500 companies – Klein Hersh’s unmatched success and critical relationships put the firm at the forefront of the industries it serves.